L3MBTL2 and pancreatic adenocarcinoma: According to the TCGA and GTEx database, L3MBTL2 expression was preferentially higher in pancreatic adenocarcinoma (PAAD) tissues (n = 179) than in nontumor tissues (n = 171) (Figure 1A).